Tirzepatide dosage chart for FDA-labeled brand dose decisions

9 min read

Share

A pale blue felt medicine calendar with a navy tablet.

TL;DR

A tirzepatide prescription lists the dose in milligrams, while a syringe may be marked in units. Those measurements are not interchangeable. Our tirzepatide dosage chart explains the usual stages of treatment, but the prescription and current product label determine the correct dose. Never change doses or convert milligrams to syringe units without confirmation from the prescriber or dispensing pharmacy.

Tirzepatide dosage chart and weekly dose stages

Tirzepatide dosage chart and weekly dose stages

Tirzepatide is generally prescribed as a once-weekly injection. Treatment begins with an initiation stage, followed by gradual dose escalation when appropriate. The maintenance dose depends on the product, treatment indication, response, side effects, and prescriber’s plan.

This quick-reference chart describes those stages without converting doses for compounded products.

Quick-reference weekly schedule

Treatment stagePurposeWhen it changes
Starting doseHelps the body adjust to treatmentAfter the label’s initiation period and prescriber review
First treatment doseBegins the ongoing treatment phaseMay be maintained or increased based on response
Escalation doseProvides a gradual step toward a higher doseOnly after enough time at the current dose
Maintenance doseSupports the agreed treatment goalContinued while effective and well tolerated
Maximum labeled doseRepresents the product label’s upper limitNo further increase without a different treatment plan

The FDA-approved products are available in several fixed strengths. We recommend checking the current label rather than relying on an old chart, saved message, or previous prescription.

Someone reading about tirzepatide 5 mg weekly should not assume that strength is automatically the next or best dose. Likewise, the 15 mg tirzepatide dose is not a goal every patient needs to reach.

What this chart does not cover

This chart does not provide compounded-vial volumes, syringe-unit conversions, or individualized dosing instructions. Concentrations and syringe markings can differ between pharmacies and products.

A universal conversion chart can therefore produce the wrong dose even when the prescribed milligrams are correct. The prescription and pharmacy label always take priority.

Starting, escalation, and maintenance doses are different

The starting dose is intended to support tolerability. It is not necessarily the dose a patient will use throughout treatment.

Escalation means moving gradually to another strength under medical supervision. A maintenance dose is the strength selected for ongoing treatment based on clinical response and side effects. Those terms should not be used interchangeably.

For Zepbound, dose selection centers on weight-management goals, tolerability, and the approved prescribing information. Mounjaro follows a stepwise approach for type 2 diabetes, with glucose response and the wider diabetes treatment plan guiding decisions.

Other medicines matter too. Insulin and sulfonylureas can increase the risk of low blood sugar when used with tirzepatide, so the prescriber may need to review more than one medication.

We do not recommend increasing simply because a higher strength exists. A steady response at a lower maintenance dose may support staying there.

When to stay at a dose or discuss an increase

When to stay at a dose or discuss an increase

More medication is not automatically better. Higher doses may bring stronger gastrointestinal side effects without enough additional benefit to justify the change.

Before discussing an increase, we recommend reviewing:

  • Time spent at the current dose
  • Weight trends rather than a single reading
  • Glucose readings, when relevant
  • Treatment goals and progress
  • Side effects and fluid intake
  • Other prescription and nonprescription medicines

Appetite alone is not a dosing rule. A few hungry days or one short plateau does not show the full treatment response.

Reasons to hold the current dose

A prescriber may consider keeping the dose unchanged when:

  • The current dose is meeting the treatment goal.
  • Side effects limit eating or drinking.
  • The current titration period is not complete.
  • Glucose readings raise concern.
  • A new medicine or health condition changes the safety plan.

Persistent vomiting after an increase calls for a clinical review, not another increase. Fluid loss can lead to dehydration and may contribute to kidney problems.

Any increase, decrease, restart, or product switch should be approved by the prescriber.

Injection day, missed doses, and treatment gaps

Tirzepatide is administered weekly, with or without food. Using the same day each week can make treatment easier to track.

Missed-dose instructions include specific timing limits, which appear in the product’s prescribing information. Because timing mistakes can lead to doses being taken too close together, we recommend checking the current label or contacting the prescriber rather than guessing.

Do not double a dose to make up for a missed injection.

Changing the weekly injection day

The product label requires a minimum interval between injections when changing the weekly day. Confirm both dates and times before making that change.

A calendar reminder or dose log can help prevent accidental early injections. If the timing is unclear, ask the prescriber or pharmacist before administering the dose.

Restarting after a long gap

Do not assume the previous dose remains appropriate after several missed injections. Tolerability may change during a break, particularly for someone who had reached a higher strength or previously experienced side effects.

Before restarting, review the exact product, current medicines, health changes, pregnancy status, and reason for the gap with the prescriber. A pharmacy or product change may also require new directions.

Side effects during tirzepatide titration

Common gastrointestinal effects include nausea, vomiting, diarrhea, constipation, reflux, and reduced appetite. These symptoms may become more noticeable after an increase.

Do not raise, lower, or stop the dose without medical guidance unless emergency instructions require immediate action. Contact the prescriber if symptoms persist, prevent fluid intake, or interfere with daily activities.

When to call the prescriber

Call the care team about:

  • Persistent nausea or vomiting
  • Dizziness, low urine output, or trouble keeping fluids down
  • Symptoms that started or worsened after an increase
  • Possible low blood sugar while using insulin or a sulfonylurea

The prescriber may review hydration, food intake, glucose readings, other medicines, and the current dose before recommending the next step.

When to seek urgent care

Severe or lasting abdominal pain, including pain that reaches the back, needs prompt assessment. Trouble breathing or swelling of the face or throat may indicate a serious tirzepatide allergic reaction.

Fainting, confusion, severe dehydration, or rapidly worsening symptoms also require urgent medical attention.

Brand products, compounded vials, and syringe units

Milligrams measure drug mass. Milliliters measure liquid volume. Syringe units are volume markings based on the syringe’s calibration.

Manufacturer-filled products deliver a labeled strength and generally do not require patients to calculate an mg-to-unit conversion. Do not remove medicine from a pen or transfer it to another container unless the manufacturer and prescriber specifically instruct you to do so.

Compounded vials are different. The same syringe marking can represent different milligram amounts when concentrations vary. Our compounded tirzepatide safety and refill guide explains why each refill must be checked independently.

Never copy dosing directions from a social media post, calculator, previous vial, or another patient’s prescription.

Details required for a liquid dose

Before administering a liquid dose, confirm:

  • The prescribed dose in milligrams
  • The exact concentration printed on the pharmacy label
  • The volume or syringe marking specified for that product and syringe

Stop if any detail is missing or inconsistent. Contact the dispensing pharmacy before injecting.

A vial’s total milligram amount does not, by itself, reveal its concentration, injection volume, number of prescribed doses, or beyond-use date. We do not recommend universal vial charts or unit calculators.

Regulatory and storage boundaries

Compounded drugs are not FDA-approved generic versions of Zepbound or Mounjaro. Their availability and appropriate use depend on individual medical needs and current compounding rules.

Our compounding pharmacy accreditation checklist can help patients assess a pharmacy. Follow the dispensing pharmacy’s storage instructions and beyond-use date rather than relying on older packaging or shortage information.

Warnings, interactions, and dose reviews

Tirzepatide carries a boxed warning concerning thyroid C-cell tumors observed in animal studies. It is contraindicated for people with certain personal or family medical histories identified in the prescribing information.

Other serious risks can include pancreatitis, gallbladder problems, kidney injury related to dehydration, and severe gastrointestinal reactions. Combining tirzepatide with insulin or a sulfonylurea can also raise the risk of hypoglycemia.

Because tirzepatide delays stomach emptying, it may affect some oral medicines. The label includes additional precautions for oral hormonal contraception after treatment begins and after dose increases.

Do not combine tirzepatide products or use tirzepatide with another GLP-1 receptor agonist unless the prescriber explicitly directs it.

Contact the prescriber before the next dose

Contact the care team before injecting if there is:

  • Pregnancy or a plan to become pregnant
  • Planned surgery, anesthesia, or deep sedation
  • A long treatment gap
  • A severe adverse effect
  • A product, pharmacy, or device change
  • A change to insulin or sulfonylurea treatment
  • A new oral medicine that may be affected by delayed stomach emptying

Refill checklist and dose log

Before paying for or using a refill, confirm:

  • Drug name and prescribed strength
  • Product form and device
  • Quantity and directions
  • Required needles or syringes
  • Concentration and volume for a liquid
  • Follow-up date

Telehealth refills still require medication reconciliation, response review, and an adverse-effect check. At usetemi.com, we use those checks to identify possible mismatches in doses, devices, and directions before the next fill.

A simple dose log can help:

DateDose in mgProductLot or pharmacyInjection siteSide effectsWeight, if relevantGlucose, if relevant

For product-specific instructions, review the current Zepbound prescribing information or Mounjaro prescribing information.

FAQ

Is the starting dose a maintenance dose?

Not necessarily. The starting dose is intended to help the body adjust to treatment. The prescriber decides when to move to a treatment or maintenance dose based on the product label, response, and tolerability.

Should I increase my dose when my appetite returns?

Not based on appetite alone. We recommend reviewing longer-term weight or glucose trends, side effects, treatment goals, and time at the current dose. Any increase should be approved by the prescriber.

What should I do if I miss more than one dose?

Contact the prescriber before restarting. A treatment gap may affect which dose is safest, particularly after previous side effects or treatment at a higher strength.

How many syringe units equal my prescribed milligrams?

There is no universal conversion. The answer depends on the liquid concentration and the syringe calibration. Confirm the exact marking with the dispensing pharmacy.

What should I check when a refill looks different?

Check the drug name, strength, product form, device, quantity, directions, and supplies. For a liquid, confirm both the concentration and injection volume. Do not reuse instructions from an older vial or prescription.

Review your dose before your next refill

If your dose, product, device, or directions have changed, request a prescription review through usetemi.com before your next injection. Have the package, pharmacy label, medication list, dose log, and side-effect notes ready.

Editorial Standards

This article has not been reviewed by a licensed physician. We cite peer-reviewed studies, academic research institutions, and medical associations. Our sources are listed at the end of each article.

If you notice an error or have a concern about our content, please email supportusetemi.com.

This article is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare provider for diagnosis and treatment.

Felt Temigami re-enacting famous revolutions, from crossing the Delaware to raising a pill-bottle flag.

The revolution will be emailed.

Once a week, roughly. We're taking the fight to a corrupt and broken health insurance system. Join up.

Get Temi's newsletter by email. Unsubscribe anytime. Privacy policy

Temi

Start online, and a licensed physician reviews your request

See if you qualify

A licensed physician reviews every request. Nothing on this page is a prescription.